A detailed history of Murphy Pohlad Asset Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Murphy Pohlad Asset Management LLC holds 3,229 shares of ABT stock, worth $429,263. This represents 0.18% of its overall portfolio holdings.

Number of Shares
3,229
Holding current value
$429,263
% of portfolio
0.18%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 17, 2025

BUY
$111.1 - $140.22 $358,741 - $452,770
3,229 New
3,229 $428,000
Q4 2018

Feb 13, 2019

BUY
$65.56 - $74.27 $94,537 - $107,097
1,442 New
1,442 $104,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $233B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Murphy Pohlad Asset Management LLC Portfolio

Follow Murphy Pohlad Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Murphy Pohlad Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Murphy Pohlad Asset Management LLC with notifications on news.